|Videos|November 25, 2019
Dr. Brad Jacobsen presentation
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
3
Eydenzelt, Celltrion’s biosimilar referencing Eylea, approved in Canada
4
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
5













































.png)


